Predictive factors of response to cyclosporine in steroid-refractory ulcerative colitis

American Journal of Gastroenterology

Volumn 103, Issue 3, 2008, Pages 637-642

  Cacheux, Wulfran ^a   Seksik, Philippe ^a   Lemann, Marc ^b   Marteau, Philippe ^c   Nion Larmurier, Isabelle ^a   Afchain, Pauline ^a   Daniel, Fady ^d,e   Beaugerie, Laurent ^a   Cosnes, Jacques ^a  

^a HÔPITAL SAINT ANTOINE   (France)

^b SAINT LOUIS HOSPITAL   (France)

^c HÔPITAL LARIBOISIÈRE   (France)

^d HÔPITAL EUROPÉEN GEORGES POMPIDOU   (France)

^e SORBONNE UNIVERSITÉ   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; C REACTIVE PROTEIN; CORTICOSTEROID; CYCLOSPORIN; INFLIXIMAB; METHOTREXATE; STEROID;

ADULT; ARTICLE; BODY TEMPERATURE; COLON RESECTION; COLONOSCOPY; CONFIDENCE INTERVAL; CONTINUOUS INFUSION; CONTROLLED STUDY; DISEASE SEVERITY; DRUG RESPONSE; FEMALE; HAZARD RATIO; HEART RATE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL DECISION MAKING; PATIENT CODING; PREDICTOR VARIABLE; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; ULCERATIVE COLITIS;

ADOLESCENT; ADRENAL CORTEX HORMONES; ADULT; AGED; COLECTOMY; COLITIS, ULCERATIVE; COLONOSCOPY; CYCLOSPORINE; DRUG RESISTANCE; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; MIDDLE AGED; RISK FACTORS; TREATMENT OUTCOME;

EID: 40949131444     PISSN: 00029270     EISSN: 15720241     Source Type: Journal    
DOI: 10.1111/j.1572-0241.2007.01653.x     Document Type: Article

References (28)

1. Edwards FC, Truelove SC. The course and prognosis of ulcerative colitis. Gut 1963 4 : 299 315.
2. Jarnerot G, Rolny P, Sandberg-Gertzen H. Intensive intravenous treatment of ulcerative colitis. Gastroenterology 1985 89 : 1005 13.
3. Truelove SC, Willoughby CP, Lee EG, et al. Further experience in the treatment of severe attacks of ulcerative colitis. Lancet 1978 2 : 1086 8.
4. Campbell S, Travis S, Jewell D. Ciclosporin use in acute ulcerative colitis: A long-term experience. Eur J Gastroenterol Hepatol 2005 17 : 79 84.
5. Cohen RD, Stein R, Hanauer SB. Intravenous cyclosporin in ulcerative colitis: A five-year experience. Am J Gastroenterol 1999 94 : 1587 92.
6. Lichtiger S, Present DH, Kornbluth A, et al. Cyclosporine in severe ulcerative colitis refractory to steroid therapy. N Engl J Med 1994 330 : 1841 5.
7. Sandborn WJ. Cyclosporine therapy for inflammatory bowel disease: Definitive answers and remaining questions. Gastroenterology 1995 109 : 1001 3.
8. Stack WA, Long RG, Hawkey CJ. Short- and long-term outcome of patients treated with cyclosporin for severe acute ulcerative colitis. Aliment Pharmacol Ther 1998 12 : 973 8.
9. Carbonnel F, Gargouri D, Lemann M, et al. Predictive factors of outcome of intensive intravenous treatment for attacks of ulcerative colitis. Aliment Pharmacol Ther 2000 14 : 273 9.
10. Ho GT, Mowat C, Goddard CJ, et al. Predicting the outcome of severe ulcerative colitis: Development of a novel risk score to aid early selection of patients for second-line medical therapy or surgery. Aliment Pharmacol Ther 2004 19 : 1079 87.
11. Lindgren SC, Flood LM, Kilander AF, et al. Early predictors of glucocorticosteroid treatment failure in severe and moderately severe attacks of ulcerative colitis. Eur J Gastroenterol Hepatol 1998 10 : 831 5.
12. Travis SP, Farrant JM, Ricketts C, et al. Predicting outcome in severe ulcerative colitis. Gut 1996 38 : 905 10.
13. Carbonnel F, Boruchowicz A, Duclos B, et al. Intravenous cyclosporine in attacks of ulcerative colitis: Short-term and long-term responses. Dig Dis Sci 1996 41 : 2471 6.
14. Rowe FA, Walker JH, Karp LC, et al. Factors predictive of response to cyclosporin treatment for severe, steroid-resistant ulcerative colitis. Am J Gastroenterol 2000 95 : 2000 8.
15. Daniel F, Loriot MA, Seksik P, et al. Multidrug resistance gene-1 polymorphisms and resistance to cyclosporine A in patients with steroid resistant ulcerative colitis. Inflamm Bowel Dis 2007 13 : 19 23.
16. Turner D, Walsh CM, Steinhart AH, et al. Response to corticosteroids in severe ulcerative colitis: A systematic review of the literature and a meta-regression. Clin Gastroenterol Hepatol 2007 5 : 103 10.
17. Jarnerot G, Hertervig E, Friis-Liby I, et al. Infliximab as rescue therapy in severe to moderately severe ulcerative colitis: A randomized, placebo-controlled study. Gastroenterology 2005 128 : 1805 11.
18. Lennard-Jones J. Classification of inflammatory bowel disease. Scand J Gastroenterol Suppl 1989 170 : 2 6.
19. Carbonnel F, Lavergne A, Lemann M, et al. Colonoscopy of acute colitis. A safe and reliable tool for assessment of severity. Dig Dis Sci 1994 39 : 1550 7.
20. Van Assche G, D'Haens G, Noman M, et al. Randomized, double-blind comparison of 4 mg/kg versus 2 mg/kg intravenous cyclosporine in severe ulcerative colitis. Gastroenterology 2003 125 : 1025 31.
21. Cottone M, Pietrosi G, Martorana G, et al. Prevalence of cytomegalovirus infection in severe refractory ulcerative and Crohn's colitis. Am J Gastroenterol 2001 96 : 773 5.
22. Papadakis KA, Tung JK, Binder SW, et al. Outcome of cytomegalovirus infections in patients with inflammatory bowel disease. Am J Gastroenterol 2001 96 : 2137 42.
23. Arts J, D'Haens G, Zeegers M, et al. Long-term outcome of treatment with intravenous cyclosporin in patients with severe ulcerative colitis. Inflamm Bowel Dis 2004 10 : 73 8.
24. Quan VA, Saunders BP, Hicks BH, et al. Cyclosporin treatment for ulcerative colitis complicated by fatal Pneumocystis carinii pneumonia. BMJ 1997 314 : 363 4.
25. Scalzini A, Barni C, Stellini R, et al. Fatal invasive aspergillosis during cyclosporine and steroids treatment for Crohn's disease. Dig Dis Sci 1995 40 : 528.
26. Gornet JM, Couve S, Hassani Z, et al. Infliximab for refractory ulcerative colitis or indeterminate colitis: An open-label multicentre study. Aliment Pharmacol Ther 2003 18 : 175 81.
27. Ochsenkuhn T, Sackmann M, Goke B. Infliximab for acute, not steroid-refractory ulcerative colitis: A randomized pilot study. Eur J Gastroenterol Hepatol 2004 16 : 1167 71.
28. Gustavsson A, Jarnerot G, Hertervig E, et al. A 2-year follow-up of the Swedish-Danish infliximab/placebo trial in steroid-resistant acute ulcerative colitis. Gastroenterology 2007 132 : 983 4.